Conquering Diseases

Investigational Study for Young Patients with Newly Diagnosed B Acute Lymphoblastic Leukemia


Seeking males & females 1-31 years of age who have completed induction therapy for B Lymphoblastic Leukemia (B-ALL) & it has has been classified as a very high risk B-ALL (VHR B-ALL).


The overall goals are to are to determine end of Consolidation disease status and better understand the effects of cancer treatment in people with VHR B-ALL.

What we're hoping for

We are hoping that an assessment of Minimal Residual Disease Evaluation (MRD), which may help determine the treatment options following Consolidation therapy.

Additional Information Identifier: NCT02883049

 Principal Investigator

Christopher  Keuker, MD

UMass Memorial Health Care

 Study Contact

Pediatrics Hem-Oncology  Research Center



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655